XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2022
Net sales and other operating revenues $ 3,994 $ 3,931 $ 4,321
Cost of sales 3,034 3,092 3,436
Gross profit 960 839 885
Selling and administrative expenses 283 253 258
Research and technical expenses 63 57 55
Loss on sale of business and asset impairment charge   3 207
Gain on bargain purchase of a business (Note C)     (24)
Income (loss) from operations 614 526 389
Interest and dividend income 32 31 11
Interest expense (81) (90) (56)
Other income (expense) (36) (16) (9)
Income (loss) from operations before income taxes and equity in earnings of affiliated companies 529 451 335
(Provision) benefit for income taxes (111) 28 (102)
Equity in earnings of affiliated companies, net of tax 6 5 10
Net income (loss) 424 484 243
Net income (loss) attributable to noncontrolling interests, net of tax of $11, $9 and $8 44 39 34
Net income (loss) attributable to Cabot Corporation $ 380 $ 445 $ 209
Weighted-average common shares outstanding:      
Basic 55.1 56.1 56.5
Diluted 55.7 56.5 56.9
Earnings (loss) per common share:      
Basic $ 6.79 $ 7.79 $ 3.65
Diluted $ 6.72 $ 7.73 $ 3.62
Purification Solutions [Member]      
Loss on sale of business and asset impairment charge     $ 197